(Q34732899)

English

Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

0 references

anti-retroviral agent

0 references

16

object named as

Max Essex

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

14

object named as

Joseph Makhema

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

object named as

Sikhulile Moyo

11

0 references

Vladimir Novitsky

4

object named as

Vladimir Novitsky

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Rosemary Musonda

12

object named as

Rosemary Musonda

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

8

object named as

Ndwapi Ndwapi

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Tendani Gaolathe

7

object named as

Tendani Gaolathe

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

6

object named as

Tanaka Muzenda

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

author name string

Hermann Bussmann

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

C William Wester

2

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Ann Thomas

3

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Reginald Okezie

5

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Norah Mawoko

9

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Erik Widenfelt

10

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Madisa Mine

13

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Howard Moffat

15

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Victor Degruttola

17

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Richard G Marlink

18

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

language of work or name

0 references

publication date

1 May 2009

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Journal of Acquired Immune Deficiency Syndromes

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

37-46

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Higher-than-expected rates of lactic acidosis among highly active antiretroviral therapy-treated women in Botswana: preliminary results from a large randomized clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

7 July 2018

The reverse transcriptase 67N 70R 215Y genotype is the predominant TAM pathway associated with virologic failure among HIV type 1C-infected adults treated with ZDV/ddI-containing HAART in southern Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

7 July 2018

Antiretroviral durability and tolerability in HIV-infected adults living in urban Kenya

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

7 July 2018

Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural Uganda

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

7 July 2018

Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings: clinical results from 4 African countries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

7 July 2018

Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

7 July 2018

HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

7 July 2018

A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

7 July 2018

First-line antiretroviral therapy in Africa--how evidence-base are our recommendations?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

7 July 2018

Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

7 July 2018

Lessons learned from use of highly active antiretroviral therapy in Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

7 July 2018

High levels of adherence do not prevent accumulation of HIV drug resistance mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

7 July 2018

Shadow on the continent: public health and HIV/AIDS in Africa in the 21st century

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

7 July 2018

Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

7 July 2018

AIDS control in sub-Saharan Africa--are more drugs and money the solution?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

7 July 2018

Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

7 July 2018

A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

7 July 2018

Adherence to antiretroviral therapy in resource-limited settings: everything matters

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

26 October 2018

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

26 October 2018

Rates of disease progression according to initial highly active antiretroviral therapy regimen: a collaborative analysis of 12 prospective cohort studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

26 October 2018

Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

26 October 2018

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

26 October 2018

Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

26 October 2018

Monitoring the response to antiretroviral therapy in resource-poor settings: the Malawi model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

26 October 2018

Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

26 October 2018

Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

26 October 2018

Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

26 October 2018

Adherence to HAART and its principal determinants in a cohort of Senegalese adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

26 October 2018

Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Côte dʼIvoire

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

26 October 2018

The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

26 October 2018

Transient relapses ("blips") of plasma HIV RNA levels during HAART are associated with drug resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

26 October 2018

A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. AIDS Clinical Trial Group 193A S

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

26 October 2018

Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group P

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066172

26 October 2018

PUBLIC HEALTH: HIV/AIDS Treatment for Millions

1 reference

https://pubmed.ncbi.nlm.nih.gov/19282782

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adherence is not a barrier to successful antiretroviral therapy in South Africa

1 reference

https://pubmed.ncbi.nlm.nih.gov/19282782

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HIV-1-infected antiretroviral-treated patients with prolonged partial viral suppression: clinical, virologic, and immunologic course

1 reference

https://pubmed.ncbi.nlm.nih.gov/19282782

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of nucleoside and nucleotide reverse transcriptase inhibitor backbones in antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19282782

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

National adult antiretroviral therapy guidelines in resource-limited countries: concordance with 2003 WHO guidelines?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19282782

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initial treatment of HIV infection: randomized trials with clinical end points are still needed

1 reference

https://pubmed.ncbi.nlm.nih.gov/19282782

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort

1 reference

https://pubmed.ncbi.nlm.nih.gov/19282782

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/QAI.0B013E31819FF102

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34732899&oldid=2119372350"